Aclarion (ACON) vs Advanced Biomed (ADVB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Aclarion is the larger company by market cap ($3.5 million vs $2.7 million), about 1.3 times the size. Advanced Biomed converts more of its revenue into profit, with a net margin of 5231.3% versus -9551.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACON | ADVB |
|---|---|---|
| Share price | $1.22 | $1.65 |
| Market cap | $3.52M | $2.73M |
| 1-day change | -13.92% | -5.71% |
| YTD return | — | -71.75% |
| 1-year return | — | -77.76% |
| EPS (TTM) | $-5.01 | $-5.03 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $75.73K | $127.64K |
| Revenue growth (YoY) | +65.62% | — |
| Net income (latest FY) | $-7.23M | $6.68M |
| Gross margin | 9.02% | — |
| Operating margin | -9312.55% | -4883.80% |
| Net margin | -9551.87% | 5231.30% |
| 52-week high | $9.36 | $24.23 |
| 52-week low | $1.22 | $1.58 |
| Distance from 52-week high | -86.94% | -93.19% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +524.18% | — |
| Average volume | 34.73K | 88.38K |
| Shares outstanding | 2.88M | 1.65M |
| Employees | 10 | 31 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Advanced Biomed is more profitable, keeping 5231.3 cents of every revenue dollar as net income versus -9551.9 cents for Aclarion.
About Aclarion
ACON stock →Aclarion, Inc. operates as a healthcare technology company in the United States.
Health Care · Medical Specialities · 10 employees
About Advanced Biomed
ADVB stock →Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product.
Health Care · Medical Specialities · 31 employees
ACON vs ADVB FAQ
Which is bigger, Aclarion or Advanced Biomed?
Aclarion (ACON) is larger, with a market capitalization of $3.52M compared with $2.73M for Advanced Biomed (ADVB).
Are Aclarion and Advanced Biomed in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.